Global HIV Therapeutics Market Growth (Status and Outlook) 2018-2023

Publisher Name :
Date: 19-Oct-2018
No. of pages: 118

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.

HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.

HIV infection has no cure but there are treatments which help to stabilize or reduce this infection so that it does not lead to AIDS. HIV therapeutics market is growing at a significant rate due to increase in the HIV infected cases and growing awareness about the same. HIV infection can be treated by various therapeutics such as nucleoside/ nucleotide reverse transcriptase inhibitor, integrase inhibitor, HIV-1 protease inhibitor, non-nucleoside reverse transcriptase inhibitor, pharmacokinetic enhancer and entry inhibitor.

Over the next five years, LPI(LP Information) projects that HIV Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global HIV Therapeutics market for 2018-2023.

This report presents a comprehensive overview, market shares and growth opportunities of HIV Therapeutics market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

- Protease Inhibitors (PIs)

- Integrase Inhibitors

- Coreceptor Antagonists

Segmentation by application:

- Hospitals

- Clinics

- Labs

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- Boehringer Ingelheim International GmbH

- Merck & Co.

- ViiV Healthcare

- AbbVie

- F. Hoffmann-La Roche Ltd.

- Teva Pharmaceutical Industries Ltd.

- Bristol-Myers Squibb

- Gilead Sciences

- Johnson & Johnson

- Cipla Limited

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global HIV Therapeutics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of HIV Therapeutics market by identifying its various subsegments.

- Focuses on the key global HIV Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the HIV Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of HIV Therapeutics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global HIV Therapeutics Market Growth (Status and Outlook) 2018-2023

Table of Contents

2018-2023 Global HIV Therapeutics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global HIV Therapeutics Market Size 2013-2023
2.1.2 HIV Therapeutics Market Size CAGR by Region
2.2 HIV Therapeutics Segment by Type
2.2.1 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
2.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.2.3 Entry and Fusion Inhibitors
2.2.4 Protease Inhibitors (PIs)
2.2.5 Integrase Inhibitors
2.2.6 Coreceptor Antagonists
2.3 HIV Therapeutics Market Size by Type
2.3.1 Global HIV Therapeutics Market Size Market Share by Type (2013-2018)
2.3.2 Global HIV Therapeutics Market Size Growth Rate by Type (2013-2018)
2.4 HIV Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Labs
2.5 HIV Therapeutics Market Size by Application
2.5.1 Global HIV Therapeutics Market Size Market Share by Application (2013-2018)
2.5.2 Global HIV Therapeutics Market Size Growth Rate by Application (2013-2018)

3 Global HIV Therapeutics by Players
3.1 Global HIV Therapeutics Market Size Market Share by Players
3.1.1 Global HIV Therapeutics Market Size by Players (2016-2018)
3.1.2 Global HIV Therapeutics Market Size Market Share by Players (2016-2018)
3.2 Global HIV Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HIV Therapeutics by Regions
4.1 HIV Therapeutics Market Size by Regions
4.2 Americas HIV Therapeutics Market Size Growth
4.3 APAC HIV Therapeutics Market Size Growth
4.4 Europe HIV Therapeutics Market Size Growth
4.5 Middle East & Africa HIV Therapeutics Market Size Growth

5 Americas
5.1 Americas HIV Therapeutics Market Size by Countries
5.2 Americas HIV Therapeutics Market Size by Type
5.3 Americas HIV Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC HIV Therapeutics Market Size by Countries
6.2 APAC HIV Therapeutics Market Size by Type
6.3 APAC HIV Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe HIV Therapeutics by Countries
7.2 Europe HIV Therapeutics Market Size by Type
7.3 Europe HIV Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa HIV Therapeutics by Countries
8.2 Middle East & Africa HIV Therapeutics Market Size by Type
8.3 Middle East & Africa HIV Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global HIV Therapeutics Market Forecast
10.1 Global HIV Therapeutics Market Size Forecast (2018-2023)
10.2 Global HIV Therapeutics Forecast by Regions
10.2.1 Global HIV Therapeutics Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global HIV Therapeutics Forecast by Type
10.8 Global HIV Therapeutics Forecast by Application

11 Key Players Analysis
11.1 Boehringer Ingelheim International GmbH
11.1.1 Company Details
11.1.2 HIV Therapeutics Product Offered
11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Boehringer Ingelheim International GmbH News
11.2 Merck & Co.
11.2.1 Company Details
11.2.2 HIV Therapeutics Product Offered
11.2.3 Merck & Co. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Merck & Co. News
11.3 ViiV Healthcare
11.3.1 Company Details
11.3.2 HIV Therapeutics Product Offered
11.3.3 ViiV Healthcare HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 ViiV Healthcare News
11.4 AbbVie
11.4.1 Company Details
11.4.2 HIV Therapeutics Product Offered
11.4.3 AbbVie HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 AbbVie News
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 Company Details
11.5.2 HIV Therapeutics Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. News
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Company Details
11.6.2 HIV Therapeutics Product Offered
11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Teva Pharmaceutical Industries Ltd. News
11.7 Bristol-Myers Squibb
11.7.1 Company Details
11.7.2 HIV Therapeutics Product Offered
11.7.3 Bristol-Myers Squibb HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Bristol-Myers Squibb News
11.8 Gilead Sciences
11.8.1 Company Details
11.8.2 HIV Therapeutics Product Offered
11.8.3 Gilead Sciences HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Gilead Sciences News
11.9 Johnson & Johnson
11.9.1 Company Details
11.9.2 HIV Therapeutics Product Offered
11.9.3 Johnson & Johnson HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Johnson & Johnson News
11.10 Cipla Limited
11.10.1 Company Details
11.10.2 HIV Therapeutics Product Offered
11.10.3 Cipla Limited HIV Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Cipla Limited News

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of HIV Therapeutics
Figure HIV Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global HIV Therapeutics Market Size Growth Rate 2013-2023 ($ Millions)
Table HIV Therapeutics Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Table Major Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table Major Players of Entry and Fusion Inhibitors
Table Major Players of Protease Inhibitors (PIs)
Table Major Players of Integrase Inhibitors
Table Major Players of Coreceptor Antagonists
Table Market Size by Type (2013-2018) ($ Millions)
Table Global HIV Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global HIV Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Market Size Growth Rate
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Market Size Growth Rate
Figure Global Entry and Fusion Inhibitors Market Size Growth Rate
Figure Global Protease Inhibitors (PIs) Market Size Growth Rate
Figure Global Integrase Inhibitors Market Size Growth Rate
Figure Global Coreceptor Antagonists Market Size Growth Rate
Figure HIV Therapeutics Consumed in Hospitals
Figure Global HIV Therapeutics Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure HIV Therapeutics Consumed in Clinics
Figure Global HIV Therapeutics Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure HIV Therapeutics Consumed in Labs
Figure Global HIV Therapeutics Market: Labs (2013-2018) ($ Millions)
Figure Global Labs YoY Growth ($ Millions)
Table Global HIV Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Global HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global HIV Therapeutics Market Size in Hospitals Growth Rate
Figure Global HIV Therapeutics Market Size in Clinics Growth Rate
Figure Global HIV Therapeutics Market Size in Labs Growth Rate
Table Global HIV Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global HIV Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global HIV Therapeutics Revenue Market Share by Players in 2017
Table Global HIV Therapeutics Key Players Head office and Products Offered
Table HIV Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global HIV Therapeutics Market Size by Regions 2013-2018 ($ Millions)
Table Global HIV Therapeutics Market Size Market Share by Regions 2013-2018
Figure Global HIV Therapeutics Market Size Market Share by Regions 2013-2018
Figure Americas HIV Therapeutics Market Size 2013-2018 ($ Millions)
Figure APAC HIV Therapeutics Market Size 2013-2018 ($ Millions)
Figure Europe HIV Therapeutics Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa HIV Therapeutics Market Size 2013-2018 ($ Millions)
Table Americas HIV Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Americas HIV Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Americas HIV Therapeutics Market Size Market Share by Countries in 2017
Table Americas HIV Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Americas HIV Therapeutics Market Size Market Share by Type (2013-2018)
Figure Americas HIV Therapeutics Market Size Market Share by Type in 2017
Table Americas HIV Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Americas HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure Americas HIV Therapeutics Market Size Market Share by Application in 2017
Figure United States HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Canada HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Mexico HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table APAC HIV Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table APAC HIV Therapeutics Market Size Market Share by Countries (2013-2018)
Figure APAC HIV Therapeutics Market Size Market Share by Countries in 2017
Table APAC HIV Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table APAC HIV Therapeutics Market Size Market Share by Type (2013-2018)
Figure APAC HIV Therapeutics Market Size Market Share by Type in 2017
Table APAC HIV Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table APAC HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure APAC HIV Therapeutics Market Size Market Share by Application in 2017
Figure China HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Japan HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Korea HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure India HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Australia HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Europe HIV Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Europe HIV Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Europe HIV Therapeutics Market Size Market Share by Countries in 2017
Table Europe HIV Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Europe HIV Therapeutics Market Size Market Share by Type (2013-2018)
Figure Europe HIV Therapeutics Market Size Market Share by Type in 2017
Table Europe HIV Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Europe HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure Europe HIV Therapeutics Market Size Market Share by Application in 2017
Figure Germany HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure France HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure UK HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Italy HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Russia HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Spain HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa HIV Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa HIV Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa HIV Therapeutics Market Size Market Share by Countries in 2017
Table Middle East & Africa HIV Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa HIV Therapeutics Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa HIV Therapeutics Market Size Market Share by Type in 2017
Table Middle East & Africa HIV Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa HIV Therapeutics Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa HIV Therapeutics Market Size Market Share by Application in 2017
Figure Egypt HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure South Africa HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Israel HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Turkey HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries HIV Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Global HIV Therapeutics arket Size Forecast (2018-2023) ($ Millions)
Table Global HIV Therapeutics Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global HIV Therapeutics Market Size Market Share Forecast by Regions
Figure Americas HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure APAC HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Europe HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure United States HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Canada HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Mexico HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Brazil HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure China HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Japan HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Korea HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Southeast Asia HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure India HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Australia HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Germany HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure France HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure UK HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Italy HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Russia HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Spain HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Egypt HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure South Africa HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Israel HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure Turkey HIV Therapeutics Market Size 2018-2023 ($ Millions)
Figure GCC Countries HIV Therapeutics Market Size 2018-2023 ($ Millions)
Table Global HIV Therapeutics Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global HIV Therapeutics Market Size Market Share Forecast by Type (2018-2023)
Table Global HIV Therapeutics Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global HIV Therapeutics Market Size Market Share Forecast by Application (2018-2023)
Table Boehringer Ingelheim International GmbH Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer Ingelheim International GmbH HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Boehringer Ingelheim International GmbH HIV Therapeutics Market Share (2016-2018)
Table Merck & Co. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck & Co. HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Merck & Co. HIV Therapeutics Market Share (2016-2018)
Table ViiV Healthcare Basic Information, Head Office, Major Market Areas and Its Competitors
Table ViiV Healthcare HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure ViiV Healthcare HIV Therapeutics Market Share (2016-2018)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure AbbVie HIV Therapeutics Market Share (2016-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Ltd. HIV Therapeutics Market Share (2016-2018)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Industries Ltd. HIV Therapeutics Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb HIV Therapeutics Market Share (2016-2018)
Table Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilead Sciences HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Gilead Sciences HIV Therapeutics Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson HIV Therapeutics Market Share (2016-2018)
Table Cipla Limited Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cipla Limited HIV Therapeutics Revenue and Gross Margin (2016-2018)
Figure Cipla Limited HIV Therapeutics Market Share (2016-2018)
  • Global Single Lead ECG Equipment Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 165
    Single lead ECG equipment is an device requires few basic actions to be operated and it is able to send transparently the acquired ECG to the designated service centre exploiting a Bluetooth connection with an Internet gateway. Application of single lead technology for monitoring heart rate during exercise, sports activities, and workout is projected to boost the adoption of these devices. According to this study, over the next five years the Single Lead ECG Equipment marke......
  • Global Seasonal Affective Disorder Therapeutics Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 139
    Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety. According to this study, over the next five years the Seasonal Affective Disorder Therapeutics market will register a x......
  • Global Circadian Rhythm Sleep Treatment Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 137
    A circadian rhythm is any biological process that displays an endogenous, entrainable oscillation of about 24 hours. These 24-hour rhythms are driven by a circadian clock, and they have been widely observed in plants, animals, fungi, and cyanobacteria. Circadian rhythm sleep treatment follows two pathways, which include utilizing drug therapy or light therapy that involves the usage of certain devices. According to this study, over the next five years the Circadian Rhythm Sleep Tr......
  • Global PET-CT Systems Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 165
    Positron emission tomography-computed tomography (better known as PET-CT or PET/CT) is a nuclear medicine technique which combines, in a single gantry, a positron emission tomography (PET) scanner and an x-ray computed tomography (CT) scanner, to acquire sequential images from both devices in the same session, which are combined into a single superposed (co-registered) image. Thus, functional imaging obtained by PET, which depicts the spatial distribution of metabolic or biochemical activity in ......
  • Global Medical Baby Monitoring Devices Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 160
    Medical Baby Monitoring Devices, also called baby monitor, is an electronic device that belonging to the home security system for active babies sleep quality testing and so on. According to this study, over the next five years the Medical Baby Monitoring Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of......
  • Global Natural Cold, Cough, and Sore Throat Remedies Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 118
    Medication for the treatment of cold, cough, and sore throat derived from natural substances fall under the purview of natural cold, cough, and sore throat remedies. According to this study, over the next five years the Natural Cold, Cough, and Sore Throat Remedies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key comp......
  • Global Auto Lensometer Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 163
    Auto Lensometer as a focimeter or vertometer, is an ophthalmic instrument. It is mainly used by optometrists and opticians to verify the correct prescription in a pair of eyeglasses, to properly orient and mark uncut lenses, and to confirm the correct mounting of lenses in spectacle frames. Lensmeters can also verify the power of contact lenses, if a special lens support is used. According to this study, over the next five years the Auto Lensometer market will register a xx% CAGR ......
  • Global Manual Lensmeter Market Growth 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 135
    Manual Lensmeter as a focimeter or vertometer, is an ophthalmic instrument. It is mainly used by optometrists and opticians to verify the correct prescription in a pair of eyeglasses, to properly orient and mark uncut lenses, and to confirm the correct mounting of lenses in spectacle frames. Lensmeters can also verify the power of contact lenses, if a special lens support is used. According to this study, over the next five years the Manual Lensmeter market will register a xx% CAG......
  • Global Photodynamic Therapy Market Growth (Status and Outlook) 2019-2024
    Published: 18-Mar-2019        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Photodynamic Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Photodynamic Therapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Photodynamic Therapy market by pr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs